DK1554305T3 - Prionprotein-bindende peptidsekvenser - Google Patents

Prionprotein-bindende peptidsekvenser

Info

Publication number
DK1554305T3
DK1554305T3 DK02779505T DK02779505T DK1554305T3 DK 1554305 T3 DK1554305 T3 DK 1554305T3 DK 02779505 T DK02779505 T DK 02779505T DK 02779505 T DK02779505 T DK 02779505T DK 1554305 T3 DK1554305 T3 DK 1554305T3
Authority
DK
Denmark
Prior art keywords
prion protein
peptide sequences
protein binding
binding peptide
prp
Prior art date
Application number
DK02779505T
Other languages
English (en)
Inventor
Theodoros Sklaviadis
Cindy Panagiotides
John Paspaltsis
Basil Karageorgis
Original Assignee
Ct For Res And Technology Hell
Cindy Panagiotides
John Paspaltsis
Basil Karageorgis
Theodoros Sklaviadis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct For Res And Technology Hell, Cindy Panagiotides, John Paspaltsis, Basil Karageorgis, Theodoros Sklaviadis filed Critical Ct For Res And Technology Hell
Application granted granted Critical
Publication of DK1554305T3 publication Critical patent/DK1554305T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02779505T 2002-10-23 2002-10-23 Prionprotein-bindende peptidsekvenser DK1554305T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2002/011868 WO2004037854A1 (en) 2002-10-23 2002-10-23 Prion protein-binding peptide sequences

Publications (1)

Publication Number Publication Date
DK1554305T3 true DK1554305T3 (da) 2007-04-23

Family

ID=32116206

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02779505T DK1554305T3 (da) 2002-10-23 2002-10-23 Prionprotein-bindende peptidsekvenser

Country Status (8)

Country Link
EP (1) EP1554305B1 (da)
AT (1) ATE358136T1 (da)
AU (1) AU2002342850A1 (da)
DE (1) DE60219215T2 (da)
DK (1) DK1554305T3 (da)
ES (1) ES2283608T3 (da)
PT (1) PT1554305E (da)
WO (1) WO2004037854A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7439041B2 (en) 2003-08-13 2008-10-21 Novartis Vaccines And Diagnostics, Inc. Prion-specific peptide reagents
WO2007030804A1 (en) 2005-09-09 2007-03-15 Novartis Ag Prion-specific peptoid reagents
EP2049664B1 (en) 2006-08-11 2011-09-14 Prosensa Technologies B.V. Single stranded oligonucleotides complementary to repetitive elements for treating DNA repeat instability associated genetic disorders
NZ582521A (en) 2007-07-12 2011-09-30 Prosensa Technologies Bv A conjugate comprising the amino acid sequence LGAQSNF for targeting compounds to muscle tissue
USRE48468E1 (en) 2007-10-26 2021-03-16 Biomarin Technologies B.V. Means and methods for counteracting muscle disorders
DK2203173T3 (da) 2007-10-26 2016-02-29 Academisch Ziekenhuis Leiden Midler og fremgangsmåder til modvirkning af muskellidelser
EP2119783A1 (en) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associated means
WO2010123369A1 (en) 2009-04-24 2010-10-28 Prosensa Technologies B.V. Oligonucleotide comprising an inosine for treating dmd
CN104203289B (zh) 2012-01-27 2020-11-03 比奥马林技术公司 用于治疗杜兴型肌营养不良症和贝克型肌营养不良症的具有改善特性的rna调节性寡核苷酸

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002514224A (ja) * 1997-06-02 2002-05-14 ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア プリオン蛋白質調節因子（ｐｐｍｆ）およびプリオン抵抗性動物
GB9823835D0 (en) * 1998-10-30 1998-12-23 Univ London Component for vaccine
US6399575B1 (en) * 1998-11-10 2002-06-04 Auburn University Methods and compositions for targeting compounds to the central nervous system
MXPA01001885A (es) * 1999-06-21 2002-04-24 Inkine Pharmaceutical Company Angiocidina: un receptor de adhesion a celula tumoral especifico de cys-ser-val-thr-cys-gly.
AU2002236499A1 (en) * 2000-11-30 2002-06-11 Uab Research Foundation Receptor-mediated uptake of peptides that bind the human transferrin receptor
CA2436789A1 (en) * 2000-12-19 2002-08-22 Palatin Technologies, Inc. Identification of target-specific folding sites in peptides and proteins

Also Published As

Publication number Publication date
EP1554305B1 (en) 2007-03-28
DE60219215D1 (de) 2007-05-10
ATE358136T1 (de) 2007-04-15
WO2004037854A1 (en) 2004-05-06
ES2283608T3 (es) 2007-11-01
AU2002342850A1 (en) 2004-05-13
DE60219215T2 (de) 2008-01-03
PT1554305E (pt) 2007-05-31
EP1554305A1 (en) 2005-07-20
AU2002342850A8 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
GB2433936A (en) Therapeutic peptides comprising sequences derived from CDR2 or CDR3 of trem-1 and uses thereof to inhibit sepsis
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
MA32982B1 (fr) Proteines de liaison au recepteur cgrp humain
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
BRPI0517973A (pt) método para purificar o fsh
WO2006023844A3 (en) Compositions and methods comprising proteinase activated receptor antagonists
WO2007076055A3 (en) Compositions and methods comprising proteinase activated receptor antagonists
NO20063064L (no) Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
NO20090624L (no) Forbindelser som modulerer CB2 receptoren
GEP20115324B (en) Tweak binding antibodies
WO2003100033A3 (en) ANTI-αvβ6 ANTIBODIES
EA200801180A1 (ru) Селективные пептидные агонисты рецептора vpac2
CY1112673T1 (el) Φαινοξυ αιθερες αμινοξεων
MX2008000230A (es) Proteinas de enlace il-6.
NO20083050L (no) Forbindelser og fremgangsmater for hemming av interaksjon av Bcl-proteiner med bindingspartnere
WO2004002418A3 (en) Compositions and methods comprising protein activated receptor antagonists
DK1554305T3 (da) Prionprotein-bindende peptidsekvenser
DE50013435D1 (de) Peptide gegen dcm hervorrufende autoantikörper
DE60207043D1 (de) Histidine-rich glycoprotein (hrgp) zur hemmung der angiogenese
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
UA87117C2 (ru) Применение пептидных соединений для лечения центральной невропатической боли
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του